According to the latest report by IMARC Group, titled “Pain Management Drugs Market Report by Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Antimigraine Agents, Antidepressants, Opioids, and Others), Indication (Musculoskeletal Pain, Surgical and Trauma Pain, Cancer Pain, Neuropathic Pain, Migraine Pain, Obstetrical Pain, Fibromyalgia Pain, Burn Pain, Dental/Facial Pain, Pediatric Pain, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033”, the global pain management drugs market size reached USD 71.4 Billion in 2024. Pain management drugs, also known as analgesics or painkillers, reduce discomfort-causing symptoms by inhibiting pain receptors. The use of these drugs is aimed at managing pain caused by inflammation in response to tissue damage, chemical agents/pathogens, or nerve damage. As a result, they are known to bind to specific proteins on the surface of cell membranes and affect the biochemical processes of the body by doing so. Numerous health problems, such as osteoarthritis, long-term arthritis, diabetic neuropathy, multiple sclerosis, and cancer, are relieved by these medications. Several over the counter (OTC) pain management drugs ease pain from chronic health conditions, such as arthritis, muscle strains and headaches. In contrast, prescription analgesics provide a better solution for severe chronic pain, trauma, injury and surgery pain relief.
Global Pain Management Drugs Market Trends:
The market is majorly driven by the rising prevalence of chronic ailments, such as osteoarthritis, diabetes, cancer and migraine, across the globe. This can be attributed to a considerable rise in the geriatric population that is susceptible of developing these conditions. In line with this, the escalating demand for non-invasive and minimally invasive surgical procedures are also providing an impetus to the market growth. Additionally, continual technological developments in the manufacturing of new pharmaceuticals, along with the introduction of new pipeline drugs are impacting the market positively. Besides this, the growing number of clinical trials and extensive research and development (R&D) activities conducted by the key players are creating lucrative growth opportunities in the market. The market is further propelled by a considerable rise in healthcare expenditure on the global level. Continual product innovations, such as the advent of novel therapies and medicines for neuropathic pain management, are also creating a positive outlook for the market. Apart from this, numerous strategies adopted by the market players, such as mergers and acquisitions (M&As) and partnerships and collaborations to enhance their geographical presence are propelling the market. Furthermore, the easy availability of numerous OTC and prescription drugs in organized retail channels, along with telemedicine and online consultation services, is providing a boost to the market. Some of the other factors contributing to the market include rapid urbanization, inflating disposable income levels, and favorable government initiatives. Looking forward, the market value is projected to reach USD 88.7 Billion by 2033, expanding at a CAGR of 2.32% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Drug Class, Indication, Distribution Channel, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Companies Covered | Abbott Laboratories, Inc., Pfizer, Inc., Eli Lilly & Company, Endo International plc, F. Hoffmann-La Roche AG, Bausch Health Companies, Inc., Merck & Co. Inc., Allergen Inc., Novartis International AG, Johnson & Johnson Private Limited, GlaxoSmithKline Plc and Purdue Pharma L.P |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800